Skip to content

Zosano Pharma Corp

Delisted

CIK 1587221fmd_15Z68M51GH26CJ1CYGEXWJVZ2CManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2014 to Mar 31, 2022, 33 periods

Latest annual · FY2021

Millions
Total revenues
1
Gross profit
(0)
Operating income
(32)
Net income
(30)
Free cash flow
(33)

Latest quarter · Q1 FY2022

Millions
Total revenues
0
Gross profit
0
Operating income
(33)
Net income
(33)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2018 to FY2021
n/m
Revenue, 5 yearsFY2016 to FY2021
n/m
Net income, 5 yearsFY2016 to FY2021
n/m

Zosano Pharma Corp financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2021FY2020ChangeSource
Revenue$785,000$224,000+250.4%10-K 2022-03-17 · proof
Gross profit-$11,000$53,000-120.8%10-K 2022-03-17 · proof
Operating income-$31.5 million-$32.8 million10-K 2022-03-17 · proof
Net income-$29.9 million-$33.4 million10-K 2022-03-17 · proof
Cash from operating activities-$27.6 million-$31.7 million10-K 2022-03-17 · proof
Free cash flow-$33 million-$40.2 million10-K 2022-03-17 · proof
What was Zosano Pharma Corp's revenue in fiscal 2021?
Zosano Pharma Corp reported revenue of $785,000 for fiscal 2021 (the year ended Dec 31, 2021), against $224,000 the year before (+250.4%). Source: the 10-K filed with the SEC on Mar 17, 2022. SEC
What was Zosano Pharma Corp's gross profit in fiscal 2021?
Zosano Pharma Corp reported gross profit of -$11,000 for fiscal 2021 (the year ended Dec 31, 2021), against $53,000 the year before (-120.8%). Source: the 10-K filed with the SEC on Mar 17, 2022. SEC
What was Zosano Pharma Corp's operating income in fiscal 2021?
Zosano Pharma Corp reported operating income of -$31.5 million for fiscal 2021 (the year ended Dec 31, 2021), against -$32.8 million the year before. Source: the 10-K filed with the SEC on Mar 17, 2022. SEC
What was Zosano Pharma Corp's net income in fiscal 2021?
Zosano Pharma Corp reported net income of -$29.9 million for fiscal 2021 (the year ended Dec 31, 2021), against -$33.4 million the year before. Source: the 10-K filed with the SEC on Mar 17, 2022. SEC
What was Zosano Pharma Corp's cash from operating activities in fiscal 2021?
Zosano Pharma Corp reported cash from operating activities of -$27.6 million for fiscal 2021 (the year ended Dec 31, 2021), against -$31.7 million the year before. Source: the 10-K filed with the SEC on Mar 17, 2022. SEC
What was Zosano Pharma Corp's free cash flow in fiscal 2021?
Zosano Pharma Corp reported free cash flow of -$33 million for fiscal 2021 (the year ended Dec 31, 2021), against -$40.2 million the year before. Source: the 10-K filed with the SEC on Mar 17, 2022. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1587221&period_type=annual&limit=5"

Information only, not investment advice.